Saha V, John T J, Mukundan P, Gnanamuthu C, Prabhakar S, Arjundas G, Sayeed Z A, Kumaresan G, Srinivas K
Department of Virology, Christian Medical College and Hospital, Vellore, India.
Epidemiol Infect. 1990 Feb;104(1):151-6. doi: 10.1017/s0950268800054637.
During 1983-7 a clinical diagnosis of subacute sclerosing panencephalitis (SSPE) was confirmed by the detection of measles virus haemagglutination inhibiting antibody in the cerebrospinal fluid (CSF) in 81 subjects resident in Tamilnadu. The antibody titre (reciprocol of the end-point dilution) in the CSF ranged from 2 to 32 and in the sera from 8 to 2048. The CSF:serum ratios of titres were 1:4-1:64 in 80 cases and 1:128 in one case. The median age at onset of SSPE was 10 years and 97% of cases were diagnosed at stage 2 and beyond. Based on the geographic distribution of 72 cases in an estimated population of 8.4 million, the annual incidence of SSPE was calculated to be 2.14 per million population, or 4.3 cases per million children below 20 years. Assuming that only 10% of all cases would have reached the level of laboratory diagnosis, the incidence may be as high as 21 cases per million population.
1983年至1987年期间,对居住在泰米尔纳德邦的81名受试者进行检测,通过在脑脊液(CSF)中检测到麻疹病毒血凝抑制抗体,证实了亚急性硬化性全脑炎(SSPE)的临床诊断。脑脊液中的抗体滴度(终点稀释倍数的倒数)范围为2至32,血清中的抗体滴度范围为8至2048。80例患者的脑脊液与血清滴度比值为1:4至1:64,1例患者为1:128。SSPE发病的中位年龄为10岁,97%的病例在2期及以后被诊断出来。根据72例病例在估计840万人口中的地理分布,计算出SSPE的年发病率为每百万人口2.14例,或每百万20岁以下儿童4.3例。假设所有病例中只有10%能够达到实验室诊断水平,发病率可能高达每百万人口21例。